How Systemic Therapy Differs From Liver-directed Therapy When Treating Patients With NETs

Pharmacy Times interviewed Gaby Gabriel, MD, program director, interventional radiology residency and assistant program director, diagnostic radiology residency, University of Kentucky, on his presentation at the 2021 NANETS Multidisciplinary Neuroendocrine Tumors (NETs) Medical Virtual Symposium discussing sequencing and combination of liver-directed therapy (LDT) with systemic therapies.

During the interview, Gabriel discussed how systemic therapy differs from LDT when treating patients with NETs.